Stock Report

All about this stock under one free report Last Updated: 30-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Henry Schein (HSIC) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$84.97

up-down-arrow $-1.02 (-1.19%)

As on 29-Sep-2026 16:08EDT

Market cap

info icon

$9,839 Mln

Revenue (TTM)

info icon

$13,602 Mln

P/E Ratio

info icon

25.2

P/B Ratio

info icon

3.1

Div. Yield

info icon

0 %

Edit peer-selector-edit
Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Market cap ($ Mln)
 9,839 24,123 10,427 10,065 9,957
Revenue ($ Mln)
 13,602 17,664 4,140 2,589 3,145
Net Profit ($ Mln)
 403.00 1,114.00 413.58 222.40 535.46
Net Margin (%)
 2.96 6.31 9.99 8.59 17.03
RoE (%)
 11.87 9.93 9.99 3.04 11.46
Price to Earnings
 25.18 18.84 25.44 45.79 19.21
Price-To-Book
 3.09 1.83 2.49 1.43 2.12

Income Statement ($ Mln)

Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Operating Revenue arrow
13,602.00 17,664.00 4,139.53 2,589.30 3,144.90
Cost of Revenue arrow
9,479.00 9,551.00 1,387.59 1,245.50 989.14
Gross Profit arrow
3,842.00 8,058.00 2,756.90 1,343.60 1,981.10
Operating Expenses arrow
3,349.00 6,392.00 2,200.16 1,108.90 1,504.66
Operating Profit (EBIT) arrow
774.00 1,721.00 551.86 235.00 652.69
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
558.00 1,477.00 568.91 350.40 664.95
Provision for Tax arrow
132.00 364.00 155.33 128.00 129.49
Profit after Tax (Net Income) arrow
403.00 1,114.00 413.58 222.40 535.46
Minority Interest arrow
-23.00 -2.00 0.00 0.00 0.00
Consolidated Profit arrow
0.00 579.00 0.00 378.10 0.00

Liabilities ($ Mln)

Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Shareholder's Funds arrow
3,157.00 11,447.00 4,232.45 7,173.90 4,768.60
Minority Interest arrow
-23.00 -2.00 0.00 0.00 0.00
Non-Current Liabilities arrow
3,170.00 7,802.00 276.53 2,116.80 240.31
Current Liabilities arrow
3,488.00 7,423.00 1,908.60 961.30 479.35
Total Liabilities arrow
11,215.00 26,944.00 6,233.69 10,576.50 5,302.76

Assets ($ Mln)

Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Non-Current Assets arrow
6,781.00 17,371.00 3,754.53 7,231.50 3,272.75
Current Assets arrow
4,600.00 9,330.00 2,663.05 3,020.50 2,215.51
Total Assets arrow
11,215.00 26,944.00 6,233.69 10,576.50 5,302.76
Total Debt* arrow
3,813.00 7,465.00 120.84 1,203.70 111.19
Net Current Assets arrow
1,112.00 1,907.00 754.45 2,059.20 1,736.17

Cashflow ($ Mln)

Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Cash From Operating Activities arrow
712.00 1,162.00 593.22 532.20 753.45
Cash Flow from Investing Activities arrow
-477.00 -737.00 -112.45 -189.70 -355.01
Cash from Financing Activities arrow
-111.00 107.00 -464.58 -283.20 -679.16
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
ROCE (%) arrow
6.03 4.64 10.09 8.98 11.44
ROE (%) arrow
11.87 9.93 9.99 3.04 11.46
ROA (%) arrow
2.80 3.29 5.00 2.02 9.43
EBIT Margin (%) arrow
5.28 10.30 15.19 -5.99 15.11
Net Margin (%) arrow
2.96 6.31 9.99 8.59 17.03
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Revenue Growth (%) arrow
6.49 -1.08 4.41 1.37 19.74
EBIT Growth (%) arrow
8.46 59.79 -3.03 -131.06 36.96
Net Profit Growth (%) arrow
3.60 587.65 -5.49 -30.32 50.14
EPS Growth (%) arrow
10.35 579.15 -2.80 -29.66 50.51
Book Value Growth (%) arrow
-1.75 8.94 9.63 2.19 9.65

Valuation Ratios

 Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Price / Earnings arrow
22.47 29.23 27.31 10.77 22.27
Price / Book Value arrow
2.76 2.39 2.77 1.10 2.62
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
12.40 11.92 13.35 6.54 15.81
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Debt to Equity arrow
0.73 0.55 0.00 0.11 0.00
Short term debt to equity ratio arrow
0.39 0.10 0.01 0.06 0.00
Current Ratio arrow
1.32 1.26 1.40 3.14 4.62
Quick Ratio arrow
0.73 0.82 1.28 2.33 2.93
Interest Coverage arrow
4.51 5.06 364.75 8.18 97.52

Operating Efficiency Ratios

 Henry Schein (HSIC) Koninklijke Philips N.V. NY Registry Shares - ADR Align Technology (ALGN) Bio-Rad Laboratories Inc. Class A (BIO) Globus Medical (GMED)
Debtors to sales (%) arrow
12.96 20.36 27.74 17.06 23.51
Asset Turnover arrow
0.95 0.52 0.50 0.24 0.55
Receivable days arrow
43.40 73.75 99.00 65.39 82.15
Inventory Days arrow
74.52 113.36 68.68 221.09 270.47
Payable days arrow
41.37 70.18 32.89 37.02 33.17
Cash Conversion Cycle arrow
76.55 116.92 134.79 249.46 319.45
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...